Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ADVENTRX Pharmaceuticals Inc (Anx) -- Ignore unavailable to you. Want to Upgrade?

To: ggamer who wrote (302)	10/1/2007 1:49:39 PM
From: estatemakr	Read Replies (2) \| Respond to of 418

I listened to the entire call, and found it to be neither hugely disappointing, nor overly optimistic. They seem to be pinning their initial reaction to the results to bolus vs. transfusional delivery. Bottom line is it is a huge setback from what was anticipated, so the drop in the stock price seems warranted :-/ Hopefully we get better results in November. Sounds like they were in very advanced partnership talks. We had a homerun if the news would have been even slightly in our favor........ Sigh! Curious to see what Keith thinks

To: ggamer who wrote (302)	10/1/2007 1:54:14 PM
From: estatemakr	Read Replies (2) \| Respond to of 418

Levine comes across more like a used care salesman than a serious CEO. His closing statement was a joke.......